Ketogenic diet may control seizures by increasing the binding potential of the benzodiazepine receptor: A speculation from the [ 11c] flumazenil-PET study

No To Hattatsu

Volumn 44, Issue 1, 2012, Pages 50-54

  Kumada, Tomohiro ^a   Nishii, Ryuichi ^b   Higashi, Tatsuya ^b   Miyajima, Tomoko ^a   Oda, Nozomi ^a   Shimomura, Hideki ^a   Saito, Keiko ^a   Fujii, Tatsuya ^a  

^a SHIGA MEDICAL CENTER FOR CHILDREN   (Japan)

^b Shiga Medical Center Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; FLUMAZENIL C 11;

ANTICONVULSANT THERAPY; ARTICLE; BINDING AFFINITY; CASE REPORT; DISEASE SEVERITY; HEAD MOVEMENT; HUMAN; INTRACTABLE EPILEPSY; KATOGENIC DIET; LIPID DIET; LOW CARBOHYDRATE DIET; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; PROTEIN RESTRICTION; TONIC SEIZURE; UNCONSCIOUSNESS;

BRAIN; CARBON RADIOISOTOPES; CHILD, PRESCHOOL; EPILEPSY, FRONTAL LOBE; FEMALE; FLUMAZENIL; GAMMA-AMINOBUTYRIC ACID; HUMANS; KETOGENIC DIET; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, GABA; RECEPTORS, GABA-A;

EID: 84856144327     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kossoff EH, McGrogan JR. Worldwide use of the ketogenic diet. Epilepsia 2005;46:280-9. (Pubitemid 40194672)
2. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007;48:43-58. (Pubitemid 46096022)
3. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32.623-48.
4. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-40. (Pubitemid 26292051)
5. Frankle WG, Cho RY, Narendran R, et al. Tiagabin increases [11C] flumazenil binding in cortical brain region in healthy control subjects. Neuropsychopharmacology 2009;34:624-33.
6. Bough K. Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet. Epilepsia 2008;49:91-3.
7. Yudkoff M, Daikhin Y, Melo TM, Nissim I. The ketogenic diet and brain metabolism of amino acids : relationship to the anticonvulsant effect. Annu Rev Nutr 2007;27:415-30. (Pubitemid 351373364)
8. Cheng CM, Hicks K, Wang J, Eagles DA, Bondy CA. Caloric restriction augments brain glutamic acid decarboxylase-65 and -67 expression. J Neurosci Res 2004;77:270-6. (Pubitemid 38859411)
9. Dahlin M, Elfving A, Ungerstedt U, Amark P. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res 2005;64:115-25. (Pubitemid 40853924)
10. Wang ZJ, Bergqvist C, Hunter JV, et al. In vivo measurement of brain metabolites using two-dimensional double-quantum MR spectroscopy-exploration of GABA levels in a ketogenic diet. Magn Reson Med 2003;49:615-9. (Pubitemid 36389969)
11. Pumain R, Ahmed MS, Kurcewicz I, et al. Lability of GABAA receptor function in human partial epilepsy:possible relationship to hypometabolism. Epilepsia 2008;49:87-90.
12. Asahina N, Shiga T, Egawa K, Shiraishi H, Kohsaka S, Saitoh S. [(11) C] flumazenil positron emission tomography analyses of brain gamma-aminobutyric acid type A receptors in Angelman syndrome. J Pediatr 2008;152:546-9.
13. Bouvard S, Costes N, Bonnefoi F, Lavenne F, Mauguiere F, Delforge J. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy:a [11C] flumazenil-PET study. Brain 2005;128:1330-43. (Pubitemid 40826187)
14. Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet : recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009;50:304-17.